Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 5
2017 5
2018 4
2019 5
2020 6
Text availability
Article attribute
Article type
Publication date

Search Results

24 results
Results by year
Filters applied: . Clear all
Page 1
Cross-neutralization of SARS coronavirus-specific antibodies against bat SARS-like coronaviruses.
Zeng LP, Ge XY, Peng C, Tai W, Jiang S, Du L, Shi ZL. Zeng LP, et al. Among authors: tai w. Sci China Life Sci. 2017 Dec;60(12):1399-1402. doi: 10.1007/s11427-017-9189-3. Epub 2017 Nov 10. Sci China Life Sci. 2017. PMID: 29134417 Free PMC article. No abstract available.
Enhanced Ability of Oligomeric Nanobodies Targeting MERS Coronavirus Receptor-Binding Domain.
He L, Tai W, Li J, Chen Y, Gao Y, Li J, Sun S, Zhou Y, Du L, Zhao G. He L, et al. Among authors: tai w. Viruses. 2019 Feb 19;11(2):166. doi: 10.3390/v11020166. Viruses. 2019. PMID: 30791410 Free PMC article.
Engineering a stable CHO cell line for the expression of a MERS-coronavirus vaccine antigen.
Nyon MP, Du L, Tseng CK, Seid CA, Pollet J, Naceanceno KS, Agrawal A, Algaissi A, Peng BH, Tai W, Jiang S, Bottazzi ME, Strych U, Hotez PJ. Nyon MP, et al. Among authors: tai w. Vaccine. 2018 Mar 27;36(14):1853-1862. doi: 10.1016/j.vaccine.2018.02.065. Epub 2018 Feb 26. Vaccine. 2018. PMID: 29496347 Free PMC article.
A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV.
Zhao G, He L, Sun S, Qiu H, Tai W, Chen J, Li J, Chen Y, Guo Y, Wang Y, Shang J, Ji K, Fan R, Du E, Jiang S, Li F, Du L, Zhou Y. Zhao G, et al. Among authors: tai w. J Virol. 2018 Aug 29;92(18):e00837-18. doi: 10.1128/JVI.00837-18. Print 2018 Sep 15. J Virol. 2018. PMID: 29950421 Free PMC article.
Cryo-Electron Microscopy Structure of Porcine Deltacoronavirus Spike Protein in the Prefusion State.
Shang J, Zheng Y, Yang Y, Liu C, Geng Q, Tai W, Du L, Zhou Y, Zhang W, Li F. Shang J, et al. Among authors: tai w. J Virol. 2018 Feb 15;92(4):e01556-17. doi: 10.1128/JVI.01556-17. J Virol. 2018. PMID: 29070693 Free PMC article.
Rational Design of Zika Virus Subunit Vaccine with Enhanced Efficacy.
Tai W, Chen J, Zhao G, Geng Q, He L, Chen Y, Zhou Y, Li F, Du L. Tai W, et al. J Virol. 2019 Aug 13;93(17):e02187-18. doi: 10.1128/JVI.02187-18. Print 2019 Sep 1. J Virol. 2019. PMID: 31189716 Free PMC article.
Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine.
Tai W, He L, Zhang X, Pu J, Voronin D, Jiang S, Zhou Y, Du L. Tai W, et al. Cell Mol Immunol. 2020 Jun;17(6):613-620. doi: 10.1038/s41423-020-0400-4. Epub 2020 Mar 19. Cell Mol Immunol. 2020. PMID: 32203189 Free PMC article.
Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry.
Wan Y, Shang J, Sun S, Tai W, Chen J, Geng Q, He L, Chen Y, Wu J, Shi Z, Zhou Y, Du L, Li F. Wan Y, et al. Among authors: tai w. J Virol. 2020 Feb 14;94(5):e02015-19. doi: 10.1128/JVI.02015-19. Print 2020 Feb 14. J Virol. 2020. PMID: 31826992 Free PMC article.
24 results
Jump to page
Feedback